ZBH
45
3
EL
59
-2
FTI
61
-2
MMC
60
3
AIV
48
4
UPS
40
2
ALLE
48
2
IBM
67
2
URBN
54
2
SIG
52
2
DTE
42
4
NVDA
57
-2
ETN
61
2
HRL
38
3
HBAN
82
2
NWL
57
3
MTB
75
2
MAS
63
3
TSN
47
3
AN
52
2
ZBH
45
3
EL
59
-2
FTI
61
-2
MMC
60
3
AIV
48
4
UPS
40
2
ALLE
48
2
IBM
67
2
URBN
54
2
SIG
52
2
DTE
42
4
NVDA
57
-2
ETN
61
2
HRL
38
3
HBAN
82
2
NWL
57
3
MTB
75
2
MAS
63
3
TSN
47
3
AN
52
2
Financhill
Back

Clover Health Investments Corp. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
35

CLOV
Clover Health Investments Corp.

Last Price:
$2.53
Seasonality Move:
-14.6%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.7200
Seasonality Move:
33.23%
Sell
35
Clover Health Investments Corp. (CLOV) is a Sell

Is Clover Health Investments Corp. a Buy, Sell or Hold?

  • The current Clover Health Investments Corp. [CLOV] share price is $2.53. The Score for CLOV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CLOV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLOV Stock Price Chart

What is Clover Health Investments Corp.'s stock price today?

  • The Clover Health Investments Corp. share price today is $2.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLOV is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

CLOV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 44.36 Sell
Chaikin Money Flow: 284881 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.4 - 2.66) Sell
Bollinger Bands (100): (2.41 - 3.13) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

CLOV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Sell
20-day SMA: 2.59 Sell
50-day SMA: 2.77 Sell
200-day SMA: 3.02 Sell
8-day EMA: 2.57 Sell
20-day EMA: 2.59 Sell
50-day EMA: 2.68 Sell
200-day EMA: 2.91 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Clover Health Investments Corp. Earnings Growth & CLOV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.02 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Clover Health Investments Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):